It’s never been more important to know the early signs of dementia and get care. Brain scans and spinal fluid tests can detect high levels of beta-amyloid and tau protein in the brain years before any symptoms develop. Those proteins create plaque in the brain linked to Alzheimer’s, the most common form of dementia.
Plus, the FDA approved Lecanemab, a drug that treats early-stage Alzheimer’s and mild cognitive impairment. It’s been shown to slow the progression of dementia up to 27% if given early.
“These biomarkers are a game changer,” says Shawn Kile, M.D., a neurologist with Sutter in Sacramento. “Today we can identify dementia early and treat it before a lot of brain changes occur. It makes a real difference.”